AEON Biopharma Inc. (AEON)
NASDAQ: AEON
· Real-Time Price · USD
0.76
-0.01 (-1.04%)
At close: Aug 18, 2025, 2:47 PM
AEON Biopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -462K | -2.32M | -4.02M | 153.47M | -74.15M | -13.97M | -13.05M | -15.03M | -9.91M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 9.1M | 2.08M | -6.17M | 164.11M | -118.02M | -15.38M | -17.64M | -34.56M | -10.44M |
Net Income | 9.1M | 2.08M | -6.17M | 164.11M | -118.02M | -15.38M | -17.64M | -34.56M | -10.44M |
Selling & General & Admin | 3.13M | 2.63M | 3.04M | 3.32M | 4.65M | 4.95M | 3.84M | 5.5M | 2.44M |
Research & Development | 825K | 3.04M | 972K | 4.44M | 5.73M | 9.03M | 9.21M | 9.53M | 7.48M |
Other Expenses | -3.49M | -3.35M | n/a | -161.23M | 63.77M | n/a | n/a | n/a | n/a |
Operating Expenses | 462K | 2.32M | 4.02M | -153.47M | 74.15M | 13.97M | 13.05M | 15.03M | 9.91M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 462K | 2.32M | 4.02M | -153.47M | 74.15M | 13.97M | 13.05M | 15.03M | 9.91M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -16.58K | -22.88K | -27.08K |
Shares Outstanding (Basic) | 3.98M | 554.26K | n/a | 539.49K | 37.27M | 380.98K | 22M | n/a | 22M |
Shares Outstanding (Diluted) | 3.98M | 555.34K | n/a | 539.49K | 37.27M | 380.98K | 22M | n/a | 22M |
EPS (Basic) | 2.28 | 3.76 | n/a | 303.84 | -227.87 | -40.37 | -0.8 | n/a | -0.47 |
EPS (Diluted) | 2.28 | 3.75 | n/a | 303.84 | -227.87 | -40.37 | -0.8 | n/a | -0.47 |
EBITDA | -3.93M | -5.64M | -3.99M | -7.74M | -10.36M | -13.95M | -13.02M | -15M | -9.91M |
EBIT | -3.95M | -5.67M | -4.02M | -7.76M | -10.38M | -13.97M | -13.05M | -15.03M | -9.91M |
Depreciation & Amortization | 19K | 23K | 25K | 24K | 25K | 23K | 25K | 32K | 27.08K |